US Stock MarketDetailed Quotes

RLAY Relay Therapeutics

Watchlist
  • 4.260
  • +0.060+1.43%
Close Dec 19 16:00 ET
  • 4.235
  • -0.025-0.59%
Post 20:01 ET
713.05MMarket Cap-1.63P/E (TTM)

Relay Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
4,327.88%10.01M
1,749.82%25.55M
-100.40%-1K
7,226.16%25.2M
-67.40%119K
-46.06%226K
-54.41%1.38M
-55.38%253K
Operating revenue
--0
--0
4,327.88%10.01M
1,749.82%25.55M
-100.40%-1K
7,226.16%25.2M
-67.40%119K
-46.06%226K
-54.41%1.38M
-55.38%253K
Cost of revenue
Gross profit
Operating expense
-3.61%96.37M
3.52%112.13M
-0.20%102.2M
29.66%404.97M
12.69%94.26M
20.49%99.98M
38.92%108.32M
51.19%102.41M
35.78%312.33M
24.01%83.65M
Selling and administrative expenses
6.84%19.75M
0.09%20.14M
1.12%19.8M
13.60%74.95M
2.41%16.77M
15.00%18.49M
15.20%20.12M
21.85%19.58M
14.97%65.98M
5.30%16.37M
-General and administrative expense
6.84%19.75M
0.09%20.14M
1.12%19.8M
13.60%74.95M
2.41%16.77M
15.00%18.49M
15.20%20.12M
21.85%19.58M
14.97%65.98M
5.30%16.37M
Research and development costs
-5.98%76.62M
4.30%91.99M
-0.51%82.4M
33.96%330.02M
15.19%77.5M
21.81%81.49M
45.76%88.2M
60.31%82.83M
42.69%246.36M
29.61%67.28M
Operating profit
-28.88%-96.37M
-3.63%-112.13M
9.77%-92.2M
-22.02%-379.42M
-13.03%-94.26M
9.50%-74.78M
-39.42%-108.2M
-51.79%-102.18M
-36.98%-310.95M
-24.68%-83.4M
Net non-operating interest income expense
5.47%8.27M
13.07%8.55M
28.96%8.95M
253.35%31.05M
61.95%8.7M
357.97%7.85M
652.14%7.56M
897.27%6.94M
958.55%8.79M
1,911.99%5.37M
Non-operating interest income
5.47%8.27M
13.07%8.55M
28.96%8.95M
253.35%31.05M
61.95%8.7M
357.97%7.85M
652.14%7.56M
897.27%6.94M
958.55%8.79M
1,911.99%5.37M
Other net income (expense)
-100.83%-10K
431.90%11.37M
85.70%1.86M
-45.06%6.4M
-80.34%2.07M
136.80%1.2M
1,274.73%2.14M
-78.14%1M
108.47%11.66M
1,358.37%10.52M
Special income (charges)
--0
428.53%11.37M
82.65%1.83M
-45.00%6.42M
-80.40%2.07M
136.79%1.2M
1,176.00%2.15M
-78.17%1M
108.48%11.68M
1,361.24%10.54M
-Less：Restructuring and merger&acquisition
--0
-428.53%-11.37M
-82.65%-1.83M
45.00%-6.42M
80.40%-2.07M
-136.79%-1.2M
-1,176.00%-2.15M
78.17%-1M
-179.48%-11.68M
-1,361.24%-10.54M
Other non- operating income (expenses)
-400.00%-10K
85.71%-2K
933.33%25K
10.00%-18K
104.17%1K
-128.57%-2K
-177.78%-14K
85.71%-3K
-400.00%-20K
---24K
Income before tax
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
21.91%-65.73M
-28.28%-98.51M
-51.89%-94.24M
20.16%-290.51M
-0.07%-67.5M
Income tax
Net income
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
21.91%-65.73M
-28.28%-98.51M
-51.89%-94.24M
20.16%-290.51M
-0.07%-67.5M
Net income continuous Operations
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
21.91%-65.73M
-28.28%-98.51M
-51.89%-94.24M
20.16%-290.51M
-0.07%-67.5M
Minority interest income
Net income attributable to the parent company
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
21.91%-65.73M
-28.28%-98.51M
-51.89%-94.24M
20.16%-290.51M
-0.07%-67.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
21.91%-65.73M
-28.28%-98.51M
-51.89%-94.24M
20.16%-290.51M
-0.07%-67.5M
Basic earnings per share
-16.67%-0.63
14.81%-0.69
20.51%-0.62
-7.72%-2.79
-19.64%-0.67
28.95%-0.54
-14.08%-0.81
-36.84%-0.78
32.20%-2.59
9.68%-0.56
Diluted earnings per share
-16.67%-0.63
14.81%-0.69
20.51%-0.62
-7.72%-2.79
-19.64%-0.67
28.95%-0.54
-14.08%-0.81
-36.84%-0.78
32.20%-2.59
9.68%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 004,327.88%10.01M1,749.82%25.55M-100.40%-1K7,226.16%25.2M-67.40%119K-46.06%226K-54.41%1.38M-55.38%253K
Operating revenue --0--04,327.88%10.01M1,749.82%25.55M-100.40%-1K7,226.16%25.2M-67.40%119K-46.06%226K-54.41%1.38M-55.38%253K
Cost of revenue
Gross profit
Operating expense -3.61%96.37M3.52%112.13M-0.20%102.2M29.66%404.97M12.69%94.26M20.49%99.98M38.92%108.32M51.19%102.41M35.78%312.33M24.01%83.65M
Selling and administrative expenses 6.84%19.75M0.09%20.14M1.12%19.8M13.60%74.95M2.41%16.77M15.00%18.49M15.20%20.12M21.85%19.58M14.97%65.98M5.30%16.37M
-General and administrative expense 6.84%19.75M0.09%20.14M1.12%19.8M13.60%74.95M2.41%16.77M15.00%18.49M15.20%20.12M21.85%19.58M14.97%65.98M5.30%16.37M
Research and development costs -5.98%76.62M4.30%91.99M-0.51%82.4M33.96%330.02M15.19%77.5M21.81%81.49M45.76%88.2M60.31%82.83M42.69%246.36M29.61%67.28M
Operating profit -28.88%-96.37M-3.63%-112.13M9.77%-92.2M-22.02%-379.42M-13.03%-94.26M9.50%-74.78M-39.42%-108.2M-51.79%-102.18M-36.98%-310.95M-24.68%-83.4M
Net non-operating interest income expense 5.47%8.27M13.07%8.55M28.96%8.95M253.35%31.05M61.95%8.7M357.97%7.85M652.14%7.56M897.27%6.94M958.55%8.79M1,911.99%5.37M
Non-operating interest income 5.47%8.27M13.07%8.55M28.96%8.95M253.35%31.05M61.95%8.7M357.97%7.85M652.14%7.56M897.27%6.94M958.55%8.79M1,911.99%5.37M
Other net income (expense) -100.83%-10K431.90%11.37M85.70%1.86M-45.06%6.4M-80.34%2.07M136.80%1.2M1,274.73%2.14M-78.14%1M108.47%11.66M1,358.37%10.52M
Special income (charges) --0428.53%11.37M82.65%1.83M-45.00%6.42M-80.40%2.07M136.79%1.2M1,176.00%2.15M-78.17%1M108.48%11.68M1,361.24%10.54M
-Less：Restructuring and merger&acquisition --0-428.53%-11.37M-82.65%-1.83M45.00%-6.42M80.40%-2.07M-136.79%-1.2M-1,176.00%-2.15M78.17%-1M-179.48%-11.68M-1,361.24%-10.54M
Other non- operating income (expenses) -400.00%-10K85.71%-2K933.33%25K10.00%-18K104.17%1K-128.57%-2K-177.78%-14K85.71%-3K-400.00%-20K---24K
Income before tax -34.03%-88.11M6.39%-92.21M13.64%-81.39M-17.72%-341.97M-23.69%-83.5M21.91%-65.73M-28.28%-98.51M-51.89%-94.24M20.16%-290.51M-0.07%-67.5M
Income tax
Net income -34.03%-88.11M6.39%-92.21M13.64%-81.39M-17.72%-341.97M-23.69%-83.5M21.91%-65.73M-28.28%-98.51M-51.89%-94.24M20.16%-290.51M-0.07%-67.5M
Net income continuous Operations -34.03%-88.11M6.39%-92.21M13.64%-81.39M-17.72%-341.97M-23.69%-83.5M21.91%-65.73M-28.28%-98.51M-51.89%-94.24M20.16%-290.51M-0.07%-67.5M
Minority interest income
Net income attributable to the parent company -34.03%-88.11M6.39%-92.21M13.64%-81.39M-17.72%-341.97M-23.69%-83.5M21.91%-65.73M-28.28%-98.51M-51.89%-94.24M20.16%-290.51M-0.07%-67.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -34.03%-88.11M6.39%-92.21M13.64%-81.39M-17.72%-341.97M-23.69%-83.5M21.91%-65.73M-28.28%-98.51M-51.89%-94.24M20.16%-290.51M-0.07%-67.5M
Basic earnings per share -16.67%-0.6314.81%-0.6920.51%-0.62-7.72%-2.79-19.64%-0.6728.95%-0.54-14.08%-0.81-36.84%-0.7832.20%-2.599.68%-0.56
Diluted earnings per share -16.67%-0.6314.81%-0.6920.51%-0.62-7.72%-2.79-19.64%-0.6728.95%-0.54-14.08%-0.81-36.84%-0.7832.20%-2.599.68%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+3.16%
Teradata Corp
TDC
+1.90%
Collegium Pharmaceutical
COLL
+1.40%
Halozyme Therapeutics
HALO
+1.02%
Hutchmed (China)
HCM
+0.90%

Unlock the Full List